» Articles » PMID: 11593386

WNT Pathway and Mammary Carcinogenesis: Loss of Expression of Candidate Tumor Suppressor Gene SFRP1 in Most Invasive Carcinomas Except of the Medullary Type

Overview
Journal Oncogene
Date 2001 Oct 11
PMID 11593386
Citations 74
Authors
Affiliations
Soon will be listed here.
Abstract

Secreted Frizzled-related protein 1 (SFRP1) encodes a member of a protein family that contains a cysteine-rich domain similar to the WNT-binding site of Frizzled receptors and regulates the WNT pathway. The WNT pathway is frequently altered in human cancers. We have defined the pattern of SFRP1 mRNA expression in the progression of breast cancer. We show that SFRP1 is expressed in the epithelial component of normal breast, in the in situ component of ductal carcinomas and is lost in more than 80% of invasive breast carcinomas except the medullary type. Loss of SFRP1 expression is correlated with the presence of hormonal receptors. Conversely, the maintenance of SFRP1 in carcinomas is correlated with the presence of lymphoplasmocytic stroma. No significant association was observed between SFRP1 status and the level of apoptosis in tumoral cells.

Citing Articles

Mechanisms of Regulation of Cell Fate in Breast Development and Cancer.

Van Keymeulen A Adv Exp Med Biol. 2025; 1464():167-184.

PMID: 39821026 DOI: 10.1007/978-3-031-70875-6_10.


Deciphering Stromal Changes between Metastatic and Non-metastatic Canine Mammary Carcinomas.

Ettlin J, Bauer A, Opitz L, Malbon A, Markkanen E J Mammary Gland Biol Neoplasia. 2023; 28(1):14.

PMID: 37391533 PMC: 10313573. DOI: 10.1007/s10911-023-09542-0.


A comprehensive review of stroke-related signaling pathways and treatment in western medicine and traditional Chinese medicine.

Chen B, Jin W Front Neurosci. 2023; 17:1200061.

PMID: 37351420 PMC: 10282194. DOI: 10.3389/fnins.2023.1200061.


Using PDX animal models to identify and stratify adenoid cystic carcinoma patients presenting an enhanced response to HDAC inhibitors.

Guimaraes L, Webber L, Gaio E, Junior D, Goncalves P, Wick M Am J Cancer Res. 2023; 13(1):143-160.

PMID: 36777521 PMC: 9906074.


Functional regulations between genetic alteration-driven genes and drug target genes acting as prognostic biomarkers in breast cancer.

Wang L, Yu L, Shi J, Li F, Zhang C, Xu H Sci Rep. 2022; 12(1):10641.

PMID: 35739271 PMC: 9226112. DOI: 10.1038/s41598-022-13835-5.